10 news items
Incyte Completes Acquisition of Escient Pharmaceuticals
INCY
30 May 24
types. In response to MRGPRX2 activation, mast cells release histamine, tryptase, chymase, chemokines and cytokines, which can cause itchy hives
9 Analysts Have This To Say About Incyte
INCY
23 May 24
and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Incyte
Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress
INCY
14 May 24
Axatilimab for Chronic Graft-Versus-Host Disease: Responses in Fibrosis
Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
INCY
30 Apr 24
with several partial responses (PR) achieved in patients with amplification/over expression of CCNE1, a cell cycle regulator and potential predictive
Peeling Back The Layers: Exploring Incyte Through Analyst Insights
INCY
23 Apr 24
Buy
$84.00
$91.00
Key Insights:
Action Taken: In response
vsd7e6cu3kwxbt9emsm1ji0idnb5j54 snwn78jn
INCY
12 Mar 24
', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Incyte. This information provides a snapshot of how
b4xvyqgpp1yjqxb7bq61e0o7627w
INCY
10 Mar 24
) diagnosed with PN who have had inadequate response or are intolerant to prior PN therapy.
The primary
oqlo2bvns ixct7dwdbuliz0ap25r58uqhc
INCY
10 Mar 24
Response (HiSCR), which indicates a 50% or greater reduction in AN count without an increase in abscesses or draining fistulas, compared to 50.0% of patients
1dw3br84710v6qbfhiyh jo16rfhv3wz70iyrbree345
INCY
4 Mar 24
Score-Plus Responses in a Randomized, Double-Blinded, Placebo-Controlled, Dose-Ranging Phase 2b Study (Abstract: #53971)All abstract
tcfng9 2q23rlko867y
INCY
4 Mar 24
of Vitiligo Area Scoring Index with Vitiligo Extent Score-Plus Responses in a Randomized, Double-Blinded, Placebo-Controlled, Dose-Ranging Phase 2b Study
- Prev
- 1
- Next